Tag: Xalkori

Home / Xalkori

Categories

Crizotinib is approved by FDA for ALK-positive inflammatory myofibroblastic tumor

 July 2022: Crizotinib (Xalkori, Pfizer Inc.) was granted approval by the Food and Drug Administration (FDA) for the treatment of adult and paediatric patients 1 year of age and older who were diagn...
xalkori

Scan the code